Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors in the brain that control the breakdown of amyloid beta, a substance that accumulates in Alzheimer's disease. According to the researchers, the study could pave the way for future drugs that are both safer and cheaper than current antibody treatments.
from Medical Xpress - latest medical and health news stories https://ift.tt/hcj8Jvz
